The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: A double-blind, placebo-controlled study

被引：127

作者：

Snow, BJ ^{[1
]}

Macdonald, L ^{[1
]}

Mcauley, D ^{[1
]}

Wallis, W ^{[1
]}

机构：

[1] Auckland Hosp, Dept Neurol, Auckland, New Zealand

来源：

CLINICAL NEUROPHARMACOLOGY | 2000年 / 23卷 / 02期

关键词：

amantadine; Parkinson's disease; dyskinesia;

D O I：

10.1097/00002826-200003000-00004

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We performed a double-blind, placebo-controlled, crossover study to assess the effect of amantadine versus placebo on levodopa-induced dyskinesias in Parkinson's disease. We found a 24% reduction in the total dyskinesia score after amantadine administration (p = 0.004). This improvement was achievement without any influence on the severity of "on" period parkinsonism. The results confirm that amantadine reduces levodopa dyskinesias and support the hypothesis that dyskinesias can be reduced by blockade of excitatory pathways in the basal ganglia.

引用

页码：82 / 85

页数：4

共 13 条

[1]

ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63

[2] Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study [J].